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Dear Editor,
The epidemiology of chronic liver diseases (CLD) in Ita-
ly is changing. This is due to the decreasing rate of viral 
hepatitis (1) and the increased number of steatosis and 
nonalcoholic steatohepatitis cases, which are emerging 
as a new epidemic with a wide spectrum of metabolic 
disorders (2). This scenario reﬂects what has occurred 
in Italy over the last few decades, as the  vaccination 
program against the Hepatitis B virus (HBV), mandatory 
since the 1991, has helped to achieve complete immuni-
zation of newborns, adolescents and young adults (3). Si-
multaneously, the epidemiology of the Hepatitis C virus 
(HCV) has evolved, due to factors such as increased blood 
transfusion safety, improvements in healthcare condi-
tions, continuing expansion of intravenous drug use 
(IDU) and immigration from endemic areas. The lack of 
a prophylactic vaccine or universally active therapy has 
made the prevention of this chronic infection extremely 
important. Identiﬁcation of infected persons and of the 
risk factors associated with acquiring a HCV infection 
may allow the development of strategies to reduce its in-
cidence and control the resulting epidemic (4). 
The prevalence of the HCV in Europe is nearly 1%, but 
this varies geographically along a north-south gradient, 
ranging from approximately 0.5% in Northern countries 
to 2% in Mediterranean areas (5). In Northern Italy, the 
Dionysos study collected data regarding 6,917 inhabit-
ants of two towns (Campogalliano and Cormons). The 
overall prevalence of positivity to the HCV antibody was 
found to be 3.2%. When the prevalence was analysed ac-
cording to diﬀerent age groups, it was relatively low ( < 
1%) up to 40 years, but the rate rose sharply thereafter, to 
reach a value of 10% in subjects older than 60 years (6). 
This suggested a cohort eﬀect. In a rural area of Central 
Italy, Raﬀaele et al. carried out a prevalence study, which 
included 344 subjects selected by random sampling 
among 3,308 inhabitants older than 16 years. The in-
ferred HCV positivity prevalence rate was 22.4% with an 
increased trend particularly evident as a result of ageing 
(7). In a Southern Italian town, Cozzolongo et al. found a 
seroprevalence for anti-HCV positivity of 2.6%; this preva-
lence increased from 1% in subjects aged < 30 years to 7.7% 
in those > 70 years (8). The incidence of HCV infection is 
very diﬃcult to estimate accurately because many pa-
tients with acute HCV infection are asymptomatic, and 
thus, do not present themselves for diagnosis (4). Data 
from the US suggests that the annual incidence of HCV 
infection fell from 230,000 new cases per year in the 125
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late 1980s to approximately 35,000 new cases per year 
in the 1990s (4). In Northern Italy, Mazzeo et al. carried 
out a study on the ten year incidence of HCV infection in 
a representative cohort of 1,646 adults from the general 
population of two Apennine hill towns. The incidence 
was 50.3 cases per 100,000 inhabitants/year while 16.9% 
of anti-HCV positive subjects spontaneously cleared the 
virus while 7 out of 11 also lost HCV-RNA from both serum 
and leukocytes (9). Although Italian scientiﬁc literature 
is rich with controversial epidemiological data obtained 
in limited populations, the pattern of HCV infection in 
the whole population overall is poorly deﬁned. In a re-
cent issue of Hepatitis Monthly, La Torre et al. estimated 
HCV infection trends in Italy during the years 1996-2006 
(10). To evaluate the incidence rates, the authors inte-
grated speciﬁc ministerial data (Ministry of Health) with 
population data from the National Institute of Statistics 
(ISTAT), a public and independent research organization. 
A strong reduction was observed in the analyzed years 
(-12,45%), distributed equally among males (-12,23%) and 
females (-12,8%). Considering all age groups, the inci-
dence rate decreased from 2.02 to 0.55 per 100,000. This 
reduction was signiﬁcant in all age groups (10). Reported 
prevalence and incidence rates of HCV infection in the 
community vary, not only depending on the speciﬁcity 
and sensitivity of the method used, but also according 
to the study design, geographical origin, and other char-
acteristics of the included populations (4). Many studies 
have been carried out in blood donors or in other spe-
ciﬁc populations (for example intravenous drug users). 
Scarce data is however available in the general popula-
tion. The strengths of the study by La Torre et al. lie in the 
study design, which included the whole population over 
a long period of follow-up, and in the use of the joinpoint 
regression method. The latter is useful in determining 
the occurrence of changes during distinct periods of 
time in trend data. Thus, it identiﬁes the calendar years 
in which statistically signiﬁcant changes in the trends 
occur, and the annual percentage of change within the 
identiﬁed period. On the other hand, the potential limi-
tations, as reported by the authors, are the poor quality 
of reporting. In conclusion, studies such as that of La 
Torre et al. (10), are crucial in increasing our knowledge 
of worldwide HCV infection rates and to plan health pol-
icy strategies.
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